Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Alcon ( (CH:ALC) ) just unveiled an announcement.
On May 13, 2025, Alcon Inc. reported its financial results for the first quarter of 2025, revealing net sales of $2.5 billion, which remained flat on a reported basis but increased by 3% on a constant currency basis compared to the previous year. The company achieved a diluted EPS of $0.70 and a core diluted EPS of $0.73. Alcon launched several innovative products, including Unity VCS and PanOptix Pro, which are expected to drive growth in the latter half of 2025 despite a challenging US market. The company’s strategic product launches and financial performance indicate a positive outlook for future growth and value creation.
The most recent analyst rating on (CH:ALC) stock is a Buy with a CHF88.90 price target. To see the full list of analyst forecasts on Alcon stock, see the CH:ALC Stock Forecast page.
More about Alcon
Alcon Inc. is a global leader in the eye care industry, known for its innovative ophthalmic products and surgical devices. The company focuses on providing solutions for eye health, including surgical instruments, implantables, and consumables, with a strong market presence worldwide.
Average Trading Volume: 1,120,800
Current Market Cap: CHF40.01B
Learn more about ALC stock on TipRanks’ Stock Analysis page.